EDAP TMS rises as Q1 revenue beats estimates

Edap Tms SA

17/05/2023 19:51

** U.S.-listed shares of medical device co EDAP TMS S.A.
 EDAP.O  up 2.9% at $11.18
    ** Co reports Q1 revenue of 14.8 mln euros ($16.29 mln) vs
estimates of 13.8 mln euros 
    ** EDAP expects sustained demand for its Focal One platform
throughout 2023
    ** Focal One is a medical device used in focal treatment of
prostate cancer using extreme temperatures to destroy tissue
    ** EDAP posts Q1 net loss of 7.5 mln euros vs net income of
0.4 mln euros a year earlier
    ** EDAP up about 4.8% YTD


($1 = 0.9084 euros)

 (Reporting by Vaibhav  Sadhamta)
 ((Vaibhav.Sadhamta@thomsonreuters.com;))